FACT CHECK: Biden correct Trump has overstated Regeneron drug's promise -- but wrong that there's no plan
BIDEN'S CLAIM: Biden said he had not seen a distribution plan for Regeneron’s monoclonal antibody treatment for COVID-19. "What's happening is there is no plan to figure out how to distribute it," he said. "How many -- you know, we have 500,000, you know, vials of it. Well, we don't have all the testing equipment. We don't have all the ability to get it to the people who need it.”
FACT CHECK: Biden is correct to suggest that Trump has overstated the promise of Regeneron's monoclonal antibody treatment for COVID-19.
However, there is a federal plan for distribution of the treatment touted by Trump.
The U.S. Department of Health and Human Services has said the government is stockpiling doses of antibody treatments for Americans and that it plans to distribute those doses to state governments and hospitals similar to how it delivered the drug remdesivir, another therapeutic that has been administered to people with COVID-19.
Since Oct. 1, hospitals have been able to purchase remdesivir, also known as Veklury, directly from the drug’s distributor. Over the past five months, the U.S. government had overseen the allocation and distribution of the drug in its limited supply.
HHS Secretary Alex Azar has said his agency does not anticipate a problem with delivering the doses so long as the drug receives authorization from regulators.
-ABC News' Arielle Mitropoulos, Sony Salzman and Anne Flaherty